Blog
25 Articles
Screening Programs Save High-Risk People
Dr. Michael Goggins explains who should undergo regular pancreatic cancer screening and where programs can be found.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
Early Detection Saved My Life
Martin Abrams and his daughter Tova have a family history of pancreatic cancer, so a screening program and early detection are paramount.
Diagnosing Pancreatic Cancer: Tests to Expect
Dr. Gobind Anand outlines the tests used to diagnose pancreatic cancer and what to expect if the disease is suspected.
Family History Matters
After Martin Abrams lost two siblings to pancreatic cancer, he made sure he was screened regularly because of his family history.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Liquid Biopsies and the Status of Pancreatic Cancer Screening
Dr. Conan Kinsey discusses the usefulness of liquid biopsies for pancreatic cancer screening and early detection.
2022 AACR Annual Meeting Update
The 2022 AACR meeting featured pancreatic cancer research in artificial intelligence, screening and earlier detection, and vaccines.
Understanding Who Is at High Risk for Pancreatic Cancer
Dr. Matthew Yurgelun explains what high risk means for pancreatic cancer, and outlines what you can do if you meet these criteria.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection
Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes, and pancreatic cancer.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint
Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother
When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve began regular screening, which lead to his early diagnosis.